Peer Review History
| Original SubmissionMay 7, 2021 |
|---|
|
Transfer Alert
This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.
PONE-D-21-15152An evidence synthesis approach for combining different data sources illustrated using entomological efficacy of insecticides for indoor residual sprayingPLOS ONE Dear Dr. Green, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 25 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Monika Gulia-Nuss, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In the Methods section, please provide additional details regarding the methodology used to identify the three datasets included in the analysis. 3. As explained in PLOS ONE's manuscript guidelines (http://journals.plos.org/plosone/s/submission-guidelines#loc-references), we do not allow citation of, or reliance on, unpublished work. Please provide the relevant information in the manuscript and/or a Supporting Information file; if the manuscript described in line 118 is accepted for publication while your PLOS ONE submission is under review, you can remove the Supporting Information file and revert to the citation in your Methods section before acceptance/publication of the current submission. 4. Please update your submission to use the PLOS LaTeX template. The template and more information on our requirements for LaTeX submissions can be found at http://journals.plos.org/plosone/s/latex. 5. Please note that in order to use the direct billing option the corresponding author must be affiliated with the chosen institute. Please either amend your manuscript to change the affiliation or corresponding author, or email us at plosone@plos.org with a request to remove this option. 6. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ 7. Please amend the manuscript submission data (via Edit Submission) to include authors Fiacre Agossa, Boulais Yovogon, Richard Oxborough, Jovin Kitau, Pie Müller,Edi Constant, Mark Rowland, Emile FS Tchacaya, Koudou G Benjamin, Thomas S Churcher, Michael Betancourt, Ellie Sherrard-Smith. 8. Please upload a copy of Supporting Material 1 ,2, and Supplementary data file 1 which you refer to in your text on page 20. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors present a well written manuscript on use of Bayesian evidence synthesis for predicting effects of indoor residual spraying. The method they propose allows combination of different data types. However, this is also the pitfall of the manuscript. As their Bayesian evidence synthesis model uses different data than the models to which is it is compared, it is challenging to draw conclusions towards differences in performance. Line 38, this reviewer does not see a need for using the registered trademark symbol in the mention of the brand name of the product under study in the abstract. Instead, the authors may use a description of the product using the trivial name, e.g. 300g/L Pirimiphos-methyl Lines 43-44 “The evidence synthesis model was most robust at predicting the probability of mosquitoes dying or surviving and blood-feeding.“ Most robust compared to what? Results Line 260: Reference to figure 5 where figure 6 is meant Figures 3& 4: at the resolution presented, the distinction between dotted and dashed lines mentioned in the legend for data from Benin and Cote d’Ivoire, respectively, is not clear Figure 5: the legend indicates that the plot shows predictions for all models but the annotations on the y-axis are not clear. What is meant with ‘aggregate after’ and aggregate before’? Where can we see the predictions for models 1, 2 and 3? Line 252-254. Indeed the uncertainty is lower for the outcomes predicted for ‘all’ compared to the other groups. But is this an intrinsic property of the model or just a result of the fact that more data is fed into this model? It is not immediate evident from the manuscript that model 3 is superior over the other models. The predictions presented in Figures 3A&C are not very different from those presented in Figure 4C, and uncertainties appear similar. The claim that the Bayesian evidence synthesis provides the best modelling option is not fully substantiated. The manuscript lacks a ‘ground truth’ to which data is compared. The approach described by the authors in lines 302-308, to created an aggregated dataset from comprehensive data, would provide a means to generate such a ground truth. It is advised that the authors include this analysis in a new version of the manuscript Conflict of interest statement Please clarify whether the authors affiliated to private entities (e.g. Abt Associates and Symplectromorphic) hold stock or performed commercial services Reviewer #2: Review of the article: “An evidence synthesis approach for combining different data sources illustrated using entomological efficacy of insecticides for indoor residual spraying” The authors describe a Bayesian evidence synthesis model and framework, building on their previously described models, to combine aggregated and comprehensive data sources for outcomes relating to mosquito feeding. The manuscript outlines the benefits and limitations of previous models and the new modelling framework, through the analysis of 23 aggregated datasets and 3 comprehensive datasets. The evidence synthesis approach is clearly described via DAGs and within the text, and the statistical differences between the previous models and the new approach are generally clearly outlined. My comments mainly relate to the presentation of some of the results: 1) One comment for the Editor, I was unable to access the Supplementary Material and Supplementary Data Files in the Editorial Manager system so my review does not include these materials 2) Throughout most of the manuscript, including the methods and results sections, the authors refer to ‘aggregated’ and ‘comprehensive’ data (i.e. referring to whether the outcomes related to mosquito feeding are published in a combined format or separated by each possible feeding outcome). In the Introduction, rather than ‘comprehensive’ data, the authors refer to ‘individual-level data’ (presumably referring to outcomes reported at an individual level, rather than mosquito level data, i.e. individual participant data, being available). I suggest sticking to the term ‘comprehensive data’ throughout and defining this term in the Introduction, to avoid confusion with individual participant data synthesis, such as IPD meta-analysis, which is a different framework entirely. 3) Some of the labelling of Figures in the text seems to be incorrect: a. Line 139: should this read Figure 2a, Model 1? b. Line 155: Which Model 2 is referred to here, Model 2a? c. Line 218: I'm not following how Figure 5 shows this, should this be Figure 6? d. Line 260: Should this read Figures 6a-c? 4) The assumption have needed to be made in previous models (e.g. Model 1), that mosquitos are equally likely to have been killed and blood-fed is described as a simplifying assumption within the Introduction. While it may be a simple assumption, I guess the key question is whether it is a reasonable assumption to make clinically or not. If I understand correctly, part of the rationale for the new Bayesian evidence synthesis framework is that this assumption is not required? But if this ‘simple’ assumption is actually reasonable, then is the added complexity (presumably) of this new framework a reasonable trade-off to not make the assumption? I think what I’m asking here is for a little more clarity on what the benefits are (if any) of the new modelling framework compared to the previous models with respect to this assumption? 5) I found the legends of most of the Figures quite unclear, specifically what each individual Figure (i.e. a – d) was showing me, i.e. which model (1, 2a/b, 3), aggregated data, comprehensive data or both etc. Although some of this information can be deduced from the text, it would be helpful to have fully descriptive legends. Specifically: a. Figure 2: A clear statement of which of these are the previously described models and which of these is the new model would be helpful. Also, not all notation is defined – e.g. the betas, Y's and N's. Again while some of this can be deduced, a full list would be helpful for completeness and particularly for readers to who may not be experts in DAGs b. Figure 3 and 4: While the general summaries are quite clear, i.e. what the shaded regions shown etc. it isn’t clear what a-d individually show (model (1, 2a/b, 3), aggregated data, comprehensive data or both etc.). I am also unable to see dotted lines and dashed lines corresponding to Benin and Côte d'Ivoire respectively on any of these Figures. c. Figure 5: Not sure I follow what aggregate data before and aggregate data after means 6) Line 248-251: “The model using comprehensive data only is very uncertain. However, these data provide worthwhile additional information when combined with the aggregate data such that the proportion survived and fed at 12 months could be approximately 10% higher than the aggregate data only model..” This is eluded to in the text below but this uncertainty is likely due to the small amount comprehensive data and the large amount of aggregate data in comparison, rather than directly due to the models themselves? Perhaps it would be better to describe that the results or estimates using comprehensive data only are uncertain, rather than the models themselves? 7) A general query, related somewhat to the discussion. The series of models here are clearly suitable for addressing the particular question in hand related to mosquito feeding but are these models ‘tailor made’ only for this question? Are there any features of the models which could be generalizable to a wider set of research questions or contexts? Bringing this out a little more in the discussion may be helpful ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Sarah J Nevitt [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
An evidence synthesis approach for combining different data sources illustrated using entomological efficacy of insecticides for indoor residual spraying PONE-D-21-15152R1 Dear Dr. Green, Thank you for your patience! The external reviewer and myself have reviewed your revised manuscript. Congratulations! The manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Monika Gulia-Nuss, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for addressing all concerns raised. The manuscript is now recommended for publication. ***** ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Koen Dechering |
| Formally Accepted |
|
PONE-D-21-15152R1 An evidence synthesis approach for combining different data sources illustrated using entomological efficacy of insecticides for indoor residual spraying Dear Dr. Green: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Monika Gulia-Nuss Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .